Big scoop: Walmart's health clinics business hit $230M in losses last year, leading to the retailer shutting it down. Shelby Livingston with the exclusive for Endpoints News endpts.com/walmart-shut-d…

Everybody gets into the GLP-1 business eventually, it seems. endpts.com/verily-gets-in…

Back from a fantastic Spain vacation and dove right into what the Chevron ruling could mean for digital health. Read it in today's edition of Endpoints' health tech newsletter: reports.endpts.com/107e23d7/91f6b…

🚨 The FTC's long-awaited report on PBMs is out 💊 endpts.com/ftc-says-pbms-…

Cancer care navigation startup Thyme Care more than doubled its valuation in its latest funding round. endpts.com/thyme-care-sco…

Nice scoop from Ngai Yeung on TMRW's lates raise-- which was significantly lower than its Series C.

Endpoints' latest health tech newsletter is out and full of good stuff. We dug into Medicare's proposed codes for digital therapeutics; Ngai Yeung scooped TMRW's raise; we learned Thyme Care's new valuation; GoodRx's biosim move + lots more. Check it out: reports.endpts.com/107e23d7/6a43a…

BREAKING: Wall Street Journal reporter Evan Gershkovich was sentenced to 16 years in prison by a Russian court in what has been widely decried as a sham trial. semafor.com/article/07/19/…

People news! Christina Farr, former OMERS VC, and Tom Cassels, former CEO of Rock Health Advisory, are headed to Manatt. endpts.com/manatt-scoops-…

New: One Medical lost its largest enterprise customer, Google, marking the latest blow to Amazon's healthcare business. businessinsider.com/google-drops-a…

New! Devoted Health just nabbed another $112 million in venture funding to fuel its push into seven new states. endpts.com/exclusive-devo…

Hims is seemingly unbothered by signs that the GLP-1 shortages could be easing, and will continue to provide compounded weight loss shots. In fact, it's buying a 503b compounding pharmacy for $31M to bolster its supply, Ngai Yeung reports. endpts.com/hims-takes-ste…

Nearly all of Novo Nordisk’s blockbuster GLP-1 Wegovy and Ozempic drugs have been taken off the FDA shortage list. endpts.com/novo-nordisk-d…

I tried to leave no stone unturned after a difficult day for Lykos and the employees there. Our Endpoints News interview with CEO Amy Emerson on what, exactly, is next: endpts.com/qa-lykos-just-…

Another leadership change at urgent/primary care chain Carbon Health. Eren Bali has handed the CEO reins to COO Kerem Ozkay. endpts.com/carbon-health-…

wow

First Eli Lilly, now Pfizer. Helping patients get around traditional healthcare channels to gain easier access to prescription drugs is catching on at big pharma companies. endpts.com/pfizer-unveils…

I spoke with UpScript, the telehealth co behind Pfizer's DTC site and others. One thing I learned: Most patients get the drug they came for. “There's clearly a bias toward what the patient wants, and that's helpful to pharma,” CEO Peter Ax told me. reports.endpts.com/107e23d7/ea775…